Results 61 to 70 of about 6,236 (164)
British Journal of Haematology, Volume 209, Issue 1, Page 349-352, July 2026.
Maria Dimou +1 more
wiley +1 more source
Transplant Infectious Disease, Volume 28, Issue 3, May/June 2026.Among patients referred for allogeneic hematopoietic cell transplantation with pulmonary opacities, lung biopsy provided a diagnosis in 72% of procedures and altered management in 51%. Despite a 7% major complication rate, lung biopsy frequently clarified noninfectious etiologies when bronchoscopy was inconclusive.
Sergio Rodriguez‐Rodriguez +8 more
wiley +1 more source
Cytomegalovirus pneumonia with pulmonary mucormycosis
Indian Journal of Pathology and Microbiology, 2008 Solid organ transplantation is becoming increasingly common in the treatment of end-stage organ failure. However, despite improvements in patient and allograft survival, immunosuppression-induced compromised cell-mediated immunity predisposes transplant recipients to opportunistic infections.
Mysorekar Vijaya, Rao Saraswati
openaire +3 more sources
Pulmonary Mucormycosis Treated With Lobectomy [PDF]
The Annals of Thoracic Surgery, 2017 A 57 year old man was referred from an outside facility for an unresolving pneumonia. Imaging of the chest demonstrated a right lung mass with a consolidation in the middle lobe, pleural effusion, and mediastinal lymphadenopathy. Cytologic examination of cultures from the bronchoscopy and thoracentesis did not yield a definitive diagnosis.
Oluwatobi, Afolayan +3 more
openaire +2 more sources
Diagnosis of Mucormycosis: Current Situation, Challenges and Future Prospects
Mycoses, Volume 69, Issue 4, April 2026.ABSTRACT Mucormycosis, an aggressive fungal infection caused by members of the order Mucorales, progresses rapidly and is associated with high mortality, particularly in immunocompromised hosts such as patients with uncontrolled diabetes, transplant recipients or those with COVID‐19‐associated immunosuppression. Early diagnosis remains challenging with
Yixuan Qu +3 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 3, March 2026.ABSTRACT Infections caused by Syncephalastrum species in humans are relatively rare. However, clinicians must maintain a high suspicion for it in immunocompromised patients with cutaneous mucormycosis. Prompt histopathological and microbiological investigations, combined with timely antifungal therapy and surgical intervention, are crucial to prevent ...
Iqra Maryam +6 more
wiley +1 more source
PLANTS, PEOPLE, PLANET, Volume 8, Issue 2, Page 499-515, March 2026.Fungal systematics can feel overwhelming given the vast species diversity within this kingdom, with numerous subgroups at every taxonomic rank. This often creates a disconnect between the undertsnidng of fungal taxonomic diversity and their societal relevance.
Anna Vaiana +4 more
wiley +1 more source
Case Reports in Infectious Diseases, 2015 Pulmonary mucormycosis is commonly encountered in patients with diabetic ketoacidosis, hematologic malignancies, neutropenia, organ or hematopoietic stem cell transplantation, and malignancy, but it rarely occurs in high-risk patients with systemic lupus
Hung-Chang Hung +6 more
doaj +1 more source
Medical Mycology Case Reports, 2017 Mucormycosis is a life threatening infection caused by fungi in the order Mucorales. Mucormycosis can affect any organ system with rhino-orbital-cerebral and pulmonary infections being the most predominant infection types.
Anthony Anderson +5 more
doaj +1 more source
Pulmonary Mucormycosis in a Hematology Ward.
Internal Medicine, 1996 During a 24-year period, seven patients with leukemia undergoing cytotoxic or immunosuppressive therapy developed pulmonary mucormycosis in our hematology ward. The autopsy incidence in patients with acute leukemia was 2.1%, with no significant rise during the last decade. Most cases occurred in early autumn.
FUNADA, Hisashi, MATSUDA, Tamotsu
openaire +3 more sources